Patents by Inventor Shilpa Nagaraju

Shilpa Nagaraju has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11549103
    Abstract: Provided is a method of producing a product by culturing a carboxydotrophic acetogenic bacterium with a disrupting mutation in a lactate dehydrogenase enzyme in the presence of a substrate comprising CO, CO2, and/or H2. Preferably, the disrupting mutation reduces or eliminates the expression or activity of the enzyme such that the bacterium produces a reduced amount of lactate or no lactate.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: January 10, 2023
    Assignee: LanzaTech NZ, Inc.
    Inventors: Shilpa Nagaraju, Bakir Al-Sinawi, Sashini De Tissera, Michael Koepke
  • Patent number: 11441149
    Abstract: The invention provides methods of genetically engineering a C1-fixing bacterium using a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated (Cas) (CRISPR/Cas) system. Preferably, the Cas protein is under the control of an inducible promoter.
    Type: Grant
    Filed: February 26, 2017
    Date of Patent: September 13, 2022
    Assignee: LanzaTech NZ, Inc.
    Inventors: Shilpa Nagaraju, Michael Koepke
  • Publication number: 20210292732
    Abstract: Disclosed herein are methods for production of 2-phenylethanol by microbial fermentation of substrates comprising carbon monoxide and/or carbon dioxide and further disclosed are genetically modified microorganisms for use in such methods. Additionally, the processes disclosed herein are improved methods of 2-PE production that alleviate dependence on natural and petrochemical processes.
    Type: Application
    Filed: January 15, 2021
    Publication date: September 23, 2021
    Inventors: Fungmin Liew, Michael Koepke, Shilpa Nagaraju, Audrey Harris
  • Publication number: 20200248152
    Abstract: Provided is a method of producing a product by culturing a carboxydotrophic acetogenic bacterium with a disrupting mutation in a lactate dehydrogenase enzyme in the presence of a substrate comprising CO, CO2, and/or H2. Preferably, the disrupting mutation reduces or eliminates the expression or activity of the enzyme such that the bacterium produces a reduced amount of lactate or no lactate.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 6, 2020
    Inventors: Shilpa Nagaraju, Bakir Al-Sinawi, Sashini De Tissera, Michael Koepke
  • Patent number: 10358661
    Abstract: The invention provides genetically engineered microorganisms with modified hydrogenase activity and methods related thereto. Typically, the microorganisms are C1-fixing microorganisms with one or more disruptive mutations in a hydrogenase enzyme or a hydrogenase accessory enzyme. The microorganisms may have improved tolerance to toxins, such as acetylene, isocyanide, ammonium, or nitric oxide, improved production of products, such as ethanol, 2,3-butanediol, and isopropanol, and/or improved fixation of carbon, such as carbon derived from CO or CO2.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: July 23, 2019
    Assignee: LANZATECH NEW ZEALAND LIMITED
    Inventors: Shilpa Nagaraju, Michael Koepke
  • Patent number: 9890384
    Abstract: Carboxydotrophic acetogenic microorganisms do not produce MEK and/or 2-butanol. They lack the biosynthesis pathways to make these products. In addition, they produce the intermediate (R,R)-2,3-butanediol whereas the production of MEK and 2-butanol requires production of the intermediate (R,S)-2,3-butanediol. Nonetheless, the production of MEK and/or 2-butanol can be accomplished using recombinant microorganisms adapted to express or overexpress key enzymes in the MEK and/or 2-butanol biosynthesis pathways. Such microorganisms, such as the carboxydotrophic acetogen Clostridium autoethanogenum, can ferment substrates comprising CO. The overall scheme involves the production of 2-butanol from (R,S)-2,3-butanediol and the conversion of (R)-acetoin to (S)-2,3-butanediol. These steps are involved in the production of both MEK and 2-butanol. Such fermentation methods offer a means of using carbon monoxide from industrial processes which would otherwise be released into the atmosphere and pollute the environment.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: February 13, 2018
    Assignee: LANZATECH NEW ZEALAND LIMITED
    Inventors: Alexander Paul Mueller, Michael Koepke, Shilpa Nagaraju
  • Publication number: 20170247710
    Abstract: The invention provides methods of genetically engineering a C1-fixing bacterium using a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated (Cas) (CRISPR/Cas) system. Preferably, the Cas protein is under the control of an inducible promoter.
    Type: Application
    Filed: February 26, 2017
    Publication date: August 31, 2017
    Inventors: Shilpa Nagaraju, Michael Koepke
  • Patent number: 9745566
    Abstract: The present provides selection markers, methods, nucleic acids, and vectors of use in the preparation of recombinant Clostridium spp.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: August 29, 2017
    Assignee: LANZATECH NEW ZEALAND LIMITED
    Inventors: David Jeffrey Fraser Walker, Shilpa Nagaraju, Michael Koepke, Alexander Paul Mueller
  • Publication number: 20170183690
    Abstract: The invention provides genetically engineered microorganisms with modified hydrogenase activity and methods related thereto. Typically, the microorganisms are C1-fixing microorganisms with one or more disruptive mutations in a hydrogenase enzyme or a hydrogenase accessory enzyme. The microorganisms may have improved tolerance to toxins, such as acetylene, isocyanide, ammonium, or nitric oxide, improved production of products, such as ethanol, 2,3-butanediol, and isopropanol, and/or improved fixation of carbon, such as carbon derived from CO or CO2.
    Type: Application
    Filed: December 21, 2016
    Publication date: June 29, 2017
    Inventors: Shilpa Nagaraju, Michael Koepke
  • Patent number: 9297026
    Abstract: The invention relates to methods for the production of chemical compounds, particularly but not exclusively ethanol, by microbial fermentation. Also described are genetically modified micro-organisms capable of using carbon monoxide to produce one or more products, particularly but not exclusively ethanol as a main product, and producing a reduced amount or substantially no 2,3-butanediol and/or a precursor thereof.
    Type: Grant
    Filed: May 4, 2015
    Date of Patent: March 29, 2016
    Assignee: LanzaTech New Zealand Limited
    Inventors: Michael Koepke, Shilpa Nagaraju, Wendy Yiting Chen
  • Publication number: 20150299737
    Abstract: The invention relates to methods for the production of chemical compounds, particularly but not exclusively ethanol, by microbial fermentation. Also described are genetically modified micro-organisms capable of using carbon monoxide to produce one or more products, particularly but not exclusively ethanol as a main product, and producing a reduced amount or substantially no 2,3-butanediol and/or a precursor thereof.
    Type: Application
    Filed: May 4, 2015
    Publication date: October 22, 2015
    Inventors: Michael Koepke, Shilpa Nagaraju, Wendy Yiting Chen
  • Publication number: 20150210987
    Abstract: The invention provides a carboxydotrophic acetogenic bacterium comprising a disrupting mutation in a lactate biosynthesis pathway enzyme and a method of producing a product by culturing the bacterium in the presence of a substrate comprising carbon monoxide. Preferably, the lactate biosynthesis pathway enzyme is lactate dehydrogenase (LDH) or another enzyme that converts pyruvate to lactate, wherein the disrupting mutation reduces or eliminates the expression or activity of the enzyme such that the bacterium produces a reduced amount of lactate or no lactate.
    Type: Application
    Filed: January 29, 2015
    Publication date: July 30, 2015
    Inventors: Shilpa Nagaraju, Bakir Al-Sinawi, Sashini De Tissera, Michael Koepke
  • Patent number: 9057071
    Abstract: The invention relates to methods for the production of chemical compounds, particularly but not exclusively ethanol, by microbial fermentation. Also described are genetically modified micro-organisms capable of using carbon monoxide to produce one or more products, particularly but not exclusively ethanol as a main product, and producing a reduced amount or substantially no 2,3-butanediol and/or a precursor thereof.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: June 16, 2015
    Assignee: LanzaTech New Zealand Limited
    Inventors: Michael Koepke, Shilpa Nagaraju, Wendy Yiting Chen
  • Publication number: 20150072395
    Abstract: The present provides selection markers, methods, nucleic acids, and vectors of use in the preparation of recombinant Clostridium spp.
    Type: Application
    Filed: September 12, 2014
    Publication date: March 12, 2015
    Inventors: David Jeffrey Fraser Walker, Shilpa Nagaraju, Michael Koepke, Alexander Paul Mueller
  • Publication number: 20140206901
    Abstract: The invention relates to methods for the production of chemical compounds, particularly but not exclusively ethanol, by microbial fermentation. Also described are genetically modified micro-organisms capable of using carbon monoxide to produce one or more products, particularly but not exclusively ethanol as a main product, and producing a reduced amount or substantially no 2,3-butanediol and/or a precursor thereof.
    Type: Application
    Filed: January 31, 2013
    Publication date: July 24, 2014
    Inventors: Michael Koepke, Shilpa Nagaraju, Wendy Yiting Chen
  • Publication number: 20130330809
    Abstract: Carboxydotrophic acetogenic microorganisms do not produce MEK and/or 2-butanol. They lack the biosynthesis pathways to make these products. In addition, they produce the intermediate (R,R)-2,3-butanediol whereas the production of MEK and 2-butanol requires production of the intermediate (R,S)-2,3-butanediol. Nonetheless, the production of MEK and/or 2-butanol can be accomplished using recombinant microorganisms adapted to express or overexpress key enzymes in the MEK and/or 2-butanol biosynthesis pathways. Such microorganisms, such as the carboxydotrophic acetogen Clostridium autoethanogenum, can ferment substrates comprising CO. The overall scheme involves the production of 2-butanol from (R,S)-2,3-butanediol and the conversion of (R)-acetoin to (S)-2,3-butanediol. These steps are involved in the production of both MEK and 2-butanol. Such fermentation methods offer a means of using carbon monoxide from industrial processes which would otherwise be released into the atmosphere and pollute the environment.
    Type: Application
    Filed: June 10, 2013
    Publication date: December 12, 2013
    Applicant: LanzaTech New Zealand Limited
    Inventors: Alexander Paul Mueller, Michael Koepke, Shilpa Nagaraju